arrow
C

Chaya Levovitz

international business machines (ibm)
H指数:13
被引数:1,685

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors

表现为多原发肿瘤的EGFR突变肺癌的发育镶嵌

2024-10-151
OAAI
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
2023-05-0934
OAAI
Mechanisms of genetic predisposition to multifocal lung cancer

多灶性肺癌的遗传易感性机制

2023-04-040
PRE
Genomic mechanisms of resistance to tyrosine kinase inhibitors (TKIs) in HER2+metastatic breast cancer (HER2+MBC)
2023-04-041
PRE
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

慢性淋巴细胞白血病向Richter综合征转化的进化史

2023-01-0940
OA
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma

与难治性b细胞淋巴瘤car-t治疗反应相关的独特细胞动力学

2022-09-12116
OA
Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis (vol 13, 898, 2022)
2022-05-102
OAAI
Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis
2022-02-2329
OAAI
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer

抗原和有效负载靶标的平行基因组改变介导三阴性乳腺癌中对Sacituzumab Govitecan的多克隆获得的临床耐药性

2021-08-1794
OAAI
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers (vol 25, pg 1415, 2019)

液体与组织活检用于检测胃肠癌的获得性耐药性和肿瘤异质性 (第25卷,1415页,2019)

2019-11-192
OAAI
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

液体与组织活检用于检测胃肠道癌症的获得性耐药性和肿瘤异质性

2019-09-09361
OAAI
Liquid biopsy versus tissue biopsy to assess acquired resistance and tumor heterogeneity in gastrointestinal cancers
2019-07-010
PRE
Broad/IBM Project: Discovery of treatment resistance mechanisms through use of liquid biopsy genomics services
2018-07-011
PRE